Self assembled, defective, nonself-propagating viral particles
AssigneeTherion Biologics Corporation
InventorsGail P. Mazzara, Dennis L. Panicali, Bryan Roberts, Linda R. Gritz, Virginia Stallard
Life of this patent
Estimating the term…
Abstract
Recombinant avipox viral vectors which express heterologous polypeptides capable of assembling into defective nonself-propagating viral particles are disclosed. The recombinant avipox viruses can be used to produce significant amounts of the heterologous polypeptides in avian or non-avian cells. Preferably, the recombinant avipox virus is a fowlpox virus. The viral particles can also be used as immunogens and for targeted delivery of heterologous gene products and drugs.
Claims6
A pharmaceutical composition, comprising a self-assembled, defective nonself-propagating viral particle produced by a eukaryotic host cell transformed by a avipox virus vector, said avipox virus vector having inserted therein, at least two DNA sequences from a single species of lentivirus DNA sequences wherein one of the lentivirus DNA sequences is selected from the group consisting of the gag gene and gag-pol gene and portions thereof, such that the lentivirus DNA sequences express gag, gag-pol proteins, and portions thereof, referred to as said first lentivirus DNA sequence and a second lentivirus DNA sequence encoding another lentiviral protein, in the eukaryotic host cell infected with the pox virus vector, wherein the lentivirus proteins or portions thereof, self-assemble into defective, non-self-propagating lentivirus particles, in a pharmaceutically acceptable vehicle.
Dependencies are inferred from the claim text.